CSC-Driven Angiogenesis

Angiogenesis, the formation of new blood vessels, is essential for tumor growth and metastasis. Cancer stem cells (CSCs) play a key role in promoting angiogenesis by secreting pro-angiogenic factors like VEGF. This track investigates how CSCs drive the formation of new vasculature to support their growth and survival in the tumor microenvironment. Researchers explore therapeutic strategies that inhibit CSC-induced angiogenesis, potentially starving tumors of the blood supply they need to grow and spread. Targeting CSCs' role in angiogenesis could lead to more effective anti-angiogenic therapies that not only shrink tumors but also prevent their recurrence and metastasis.

    Related Conference of CSC-Driven Angiogenesis

    February 05-06, 2026

    11th World Conference on Breast and Cervical Cancer

    Paris, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 09-10, 2026

    4th World Congress on Oral Cancer

    Singapore City, Singapore
    March 30-31, 2026

    26th World Congress on Cancer and Diagnostics

    London, UK
    June 15-16, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    June 22-23, 2026

    16th World Congress on Breast Cancer

    Dubai, UAE
    June 23-24, 2026

    27th World Congress on Cancer Summit

    Paris, France
    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    September 29-30, 2026

    5th Experts Meeting on Cancer Medicine, Radiology & Treatment

    Aix-en-Provence, France

    CSC-Driven Angiogenesis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in